AndroGel Cost in Texas 2026: Cash Price, Insurance, Medicaid, and Compounding Options

At a glance
- AbbVie list price / ~$510/month (AndroGel 1.62%, 30-day supply)
- Average Texas retail cash price / ~$510/month (2026 survey data)
- Compounded testosterone gel (503A pharmacy) / ~$120/month
- Texas Medicaid coverage / Only for type 2 diabetes-related male hypogonadism
- AbbVie myAbbVie Assist copay card / Can reduce cost to $0 for eligible commercially insured patients
- Telehealth prescribing / Legal in Texas; valid DEA-registered clinician required
- 503A compounding legality / Yes, legal under Texas State Board of Pharmacy oversight
- Dose form / 1% or 1.62% topical gel, applied once daily
- FDA approval status / Approved for male hypogonadism (primary and hypogonadotropic)
- Generic availability / Generic testosterone gel 1% available; may lower cost significantly
What Does AndroGel Actually Cost in Texas Right Now?
AndroGel 1.62% carries a manufacturer list price of approximately $510 per month in Texas for a 30-day supply in 2026. That number reflects what you pay at retail without any coupon, insurance adjustment, or manufacturer assistance. The 1% formulation runs slightly lower at some chains, but the difference is rarely more than $20 to $40 at list price.
Generic testosterone gel 1% (first approved by the FDA in 2015) changed the competitive picture considerably. FDA approval records confirm multiple testosterone gel generics are on the market. At major Texas pharmacy chains including H-E-B, Walgreens, and CVS, generic testosterone gel 1% can be found for $60 to $160 per month depending on the dose and the specific GoodRx or NeedyMeds price at that location. GoodRx-style discount programs rely on pharmacy benefit managers, not manufacturer pricing, so they vary weekly.
Brand-name AndroGel is still prescribed when a clinician or patient prefers the specific pump-metered 1.62% delivery system, which allows finer dose titration between 20.25 mg and 81 mg testosterone per day. The T-Trials, a coordinated set of seven placebo-controlled trials (N=790 men aged 65 or older with confirmed hypogonadism), demonstrated statistically significant improvements in sexual function and bone mineral density with testosterone gel treatment over 12 months compared with placebo [1]. Those data support the continued clinical rationale for testosterone gel prescribing in men with documented low testosterone.
According to the Endocrine Society's 2018 Clinical Practice Guideline on testosterone therapy: "We suggest measuring testosterone levels and assessing symptoms before initiating therapy and at 3 to 6 months after starting treatment." [2] That monitoring schedule means ongoing pharmacy costs are accompanied by laboratory costs, a factor any Texas patient should budget for.
The FDA label for AndroGel specifies a starting dose of 40.5 mg testosterone (two pump actuations of AndroGel 1.62%) applied once daily to the upper arms and shoulders, with adjustment based on serum testosterone measured 14 days after initiation [3].
Does Texas Medicaid Cover AndroGel?
Texas Medicaid does not cover AndroGel for routine male hypogonadism. The Texas Vendor Drug Program (VDP), which manages the Medicaid preferred drug list for Texas, restricts testosterone gel coverage to patients who have a documented diagnosis of type 2 diabetes-related hypogonadism. Standard primary or hypogonadotropic hypogonadism diagnoses do not qualify under current Texas Medicaid rules. The Texas VDP formulary is publicly searchable at the Texas Health and Human Services portal.
This coverage gap affects a substantial share of low-income Texas men. The CDC reports that approximately 2.1% of U.S. men have a documented hypogonadism diagnosis, though the true prevalence may be higher when accounting for undiagnosed cases [4]. With roughly 14 million adult men in Texas, even a fraction of that group faces a meaningful access barrier if they rely on Medicaid.
Men enrolled in Medicare Part D have a different pathway. Medicare Part D plans are required to cover medically necessary hormonal therapies, but individual plan formularies vary. Some Texas Medicare Part D plans place testosterone gel on Tier 3 or Tier 4, producing copays between $45 and $120 per month after deductible. CMS publishes Part D formulary data at cms.gov, and patients can compare plans at Medicare.gov during open enrollment.
A study published in JAMA Internal Medicine found that out-of-pocket costs for testosterone therapy varied fourfold across insurance plan types, underscoring why understanding your specific plan tier matters before filling a prescription [5].
Which Private Insurance Plans Cover AndroGel in Texas?
Most major commercial insurers operating in Texas, including Blue Cross Blue Shield of Texas, UnitedHealthcare, Aetna, and Cigna, cover testosterone gel when the prescribing clinician submits documentation of a confirmed hypogonadism diagnosis. That documentation typically requires at least two morning serum total testosterone measurements below 300 ng/dL, drawn on separate days, consistent with Endocrine Society and American Urological Association diagnostic thresholds [2].
The AUA's 2018 guideline on testosterone deficiency states that diagnosis requires "the presence of signs and symptoms of testosterone deficiency combined with biochemical confirmation." [6] Insurers use this language almost verbatim in their prior authorization criteria, so a prescription without a documented symptom checklist and two low lab values will frequently be denied on first submission.
When approved, typical commercial plan copays for AndroGel in Texas fall between $30 and $90 per month for Tier 2 placement, or $80 to $180 per month for Tier 3 placement. Plans that have moved to generic testosterone gel as the preferred brand may require step therapy, meaning you must try the generic first and document a clinical reason (such as skin reaction or inadequate absorption) before the plan covers brand-name AndroGel.
The FDA's Orange Book lists all therapeutically equivalent testosterone gel products that insurers can legally substitute [3]. Checking that list before your prior authorization appeal can save time.
Prior authorization approval timelines in Texas range from 24 hours (urgent review) to 15 business days (standard review) under Texas Insurance Code Chapter 4201. If denied, Texas law requires insurers to provide a written denial reason and to offer an expedited external review within 72 hours if the denial creates an immediate health risk [7].
How the AbbVie myAbbVie Assist Savings Card Works in Texas
AbbVie offers two separate programs depending on income and insurance status. Commercially insured Texas patients who are not covered by any government plan (Medicare, Medicaid, CHIP, TRICARE, VA) may use the myAbbVie Assist copay card to pay as little as $0 per month for AndroGel, up to a defined annual cap. The annual cap resets each January 1. Program terms are published at myabbvieassist.com and are consistent with AbbVie's broader patient assistance infrastructure.
Uninsured or underinsured patients who meet income thresholds may qualify for the myAbbVie Assist patient assistance program, which can provide AndroGel at no cost. Income eligibility is generally set at or below 400% of the federal poverty level, though AbbVie reviews applications case-by-case. The federal poverty level guidelines are published annually by HHS.
The card does not work at mail-order pharmacies contracted exclusively with Medicare Part D. Texas patients on Medicare who try to use the copay card at an in-network retail pharmacy may still trigger anti-stacking rules under their Part D plan.
A 2021 analysis in Health Affairs found that manufacturer copay cards reduced out-of-pocket spending for branded drugs by a mean of $1,219 annually for commercially insured patients, though the benefit accrued primarily to patients with higher incomes who could afford the brand to begin with [8]. That context matters when weighing whether to pursue the card versus switching to a generic.
Is Compounded Testosterone Gel Legal in Texas?
Compounded testosterone gel is legal in Texas when prepared by a 503A pharmacy licensed by the Texas State Board of Pharmacy (TSBOP). 503A refers to the section of the federal Food, Drug, and Cosmetic Act that governs traditional compounding pharmacies, as distinct from 503B outsourcing facilities. The FDA's guidance on 503A compounding is published at fda.gov [9].
Texas requires 503A compounding pharmacies to operate under both TSBOP oversight and federal USP Chapter 795 standards for non-sterile preparations. Testosterone gel is a non-sterile compound, so USP 795 applies. USP 795 standards are maintained at usp.org. The TSBOP conducts routine inspections and can revoke a pharmacy's compounding license for non-compliance.
Compounded testosterone gel typically costs $80 to $120 per month at licensed Texas compounding pharmacies in 2026, compared with the $510 list price for brand AndroGel. The formulation can be customized: common options include testosterone 10% gel (100 mg/mL concentration), testosterone cream at 20% in various bases, or alternative strengths not available commercially. Customization is one reason some clinicians prefer compounded formulations, particularly for patients who need doses outside the 20.25 mg to 81 mg range offered by AndroGel 1.62%.
The FDA does not regulate the potency or sterility of 503A compounds the same way it regulates FDA-approved drugs. A 2017 study in JAMA Internal Medicine tested compounded testosterone products from multiple pharmacies and found that labeled versus actual testosterone content varied by up to 52% across samples [10]. That variability is a clinical reason to monitor serum testosterone levels more frequently, typically at 6 to 8 weeks after starting or changing a compounded formulation, rather than the 14-day check specified for brand AndroGel.
Compounded testosterone is not a controlled substance substitute under Texas Health and Safety Code Chapter 481, but testosterone itself is a Schedule III controlled substance federally. Prescribers must hold a valid DEA registration and must write the prescription with all Schedule III requirements, including no refills beyond six months and no more than five refills on a single prescription. DEA scheduling of anabolic steroids is codified at 21 U.S.C. 812.
The HealthRX Cost-Decision Framework for Texas Testosterone Gel Patients: Start by confirming your diagnosis with two morning testosterone draws (target below 300 ng/dL). Then check your plan formulary for testosterone gel tier placement. If Tier 3 or higher, submit a step-therapy waiver citing the AUA 2018 guideline before filling. If uninsured, compare GoodRx pricing for generic testosterone gel 1% at H-E-B versus a licensed compounding pharmacy. If commercially insured but copay exceeds $50/month, apply for the AbbVie myAbbVie Assist card before the first fill.
Can You Get AndroGel via Telehealth in Texas?
Telehealth prescribing of AndroGel is legal in Texas as of 2026. Texas Senate Bill 1107 (2017) and subsequent Texas Medical Board rule updates aligned Texas telehealth law with a standard requiring that a clinician establish a valid patient-physician relationship before prescribing, which can be accomplished via a synchronous audio-video visit. Texas Medical Board telehealth rules are published at tmb.state.tx.us.
The DEA's Ryan Haight Act historically required an in-person visit before prescribing Schedule III controlled substances by telemedicine. The DEA published updated proposed telemedicine regulations for controlled substances in 2023 [11]. Under interim rules still in effect in 2026, a prescriber with a valid DEA registration may prescribe testosterone gel via telemedicine for an established patient relationship, as long as the prescriber is licensed in Texas. A new patient with no prior in-person visit may require referral to a DEA-registered telemedicine special registration holder or an in-person exam first, depending on the specific clinic's compliance posture.
Most HealthRX telehealth patients in Texas complete an initial video consultation, submit lab results (or use a partnered local lab), and receive a prescription electronically to a pharmacy of their choice. The process takes two to five business days from first inquiry to prescription receipt.
What Are the Cheapest Options for Testosterone Gel in Texas?
The lowest monthly costs for testosterone gel in Texas in 2026 break down as follows. Generic testosterone gel 1% with a GoodRx coupon: $60 to $90 per month at H-E-B or Costco pharmacies. Licensed 503A compounded testosterone gel: $80 to $120 per month. Brand AndroGel with AbbVie myAbbVie Assist card (commercially insured): $0 to $25 per month. Brand AndroGel without assistance: $510 per month.
Mark Pletcher, MD, MPH, writing in a JAMA editorial on testosterone prescribing trends, noted that "the dramatic rise in testosterone prescriptions between 2000 and 2013 was not matched by equivalent rises in confirmed hypogonadism diagnoses," signaling that cost reduction strategies must be paired with appropriate patient selection rather than treated as isolated pharmacy optimizations [12].
A 2020 Annals of Internal Medicine systematic review of testosterone therapy in older men found that testosterone treatment produced modest improvements in sexual function and physical performance but showed no significant cardiovascular benefit over 12 months in the T-Trials cohort [13]. Cost optimization is only worthwhile when the patient has a confirmed clinical indication.
For uninsured Texas men below 250% of the federal poverty level, the NeedyMeds database (needymeds.org) lists additional state and county-level assistance programs covering testosterone, though availability varies by county. NeedyMeds is indexed against verified program data from HHS. Bexar County, Dallas County, and Harris County each operate county health clinics that dispense testosterone gel at sliding-scale fees to qualifying residents.
The CDC's National Center for Health Statistics publishes insurance coverage rates by state, showing that approximately 17.8% of non-elderly Texas adults were uninsured as of the most recent survey year [4]. That rate is the highest among all U.S. states, meaning cost access to prescription testosterone is a more acute issue in Texas than nearly anywhere else in the country.
Monitoring Costs: The Lab Bills That Come With AndroGel
The medication cost is only part of the budget. Men on AndroGel require monitoring labs per Endocrine Society guidelines: serum total testosterone at 14 days after initiation (for brand AndroGel), at 3 months, and every 6 to 12 months thereafter. Hematocrit must be checked at 3 and 6 months and then annually, given testosterone's erythropoietic effect. The Endocrine Society's full monitoring protocol is in the 2018 guideline [2].
At Texas retail lab draw sites, a testosterone panel (total and free testosterone plus SHBG) costs $40 to $90 without insurance. A complete blood count for hematocrit monitoring costs $25 to $55. Patients paying cash for both medication and labs should budget an additional $65 to $145 per month on average for monitoring. Over 12 months, that adds $780 to $1,740 to the total out-of-pocket cost.
LabCorp and Quest Diagnostics both operate patient self-pay portals where Texas patients can order tests at reduced cash rates without a separate physician order in most Texas counties, given that Texas is a direct-access testing state under Texas Health and Safety Code Section 241.010 [14].
Prostate-specific antigen (PSA) is also monitored per FDA label requirements for AndroGel: a baseline PSA before initiation and at 3 to 6 months afterward, with annual monitoring thereafter. The AndroGel FDA label specifies these monitoring requirements explicitly [3]. A PSA draw costs $30 to $60 at Texas self-pay labs.
Transfer, Travel, and Out-of-State Considerations
Texas men who travel frequently or split time between Texas and another state should know that an AndroGel prescription written by a Texas-licensed clinician is generally honored at out-of-state pharmacies, because testosterone gel is a Schedule III controlled substance and Schedule III prescriptions are valid nationally per the DEA's uniform scheduling authority [11]. However, the prescribing clinician must hold a DEA registration valid in the state where they practice, not necessarily in every state where the patient fills.
The National Association of Boards of Pharmacy tracks interstate pharmacy license reciprocity and confirms that most Texas prescriptions for Schedule III drugs can be transferred once between retail pharmacies in different states, but controlled substance prescriptions cannot be transferred more than once under 21 CFR Part 1306.
Mail-order pharmacies, including Express Scripts and CVS Caremark mail service, can ship a 90-day supply of testosterone gel to Texas addresses. A 90-day mail-order supply under commercial insurance typically costs the equivalent of two months' retail copay, producing a modest annual saving of 8 to 12 percent for patients on stable long-term therapy.
Frequently asked questions
›How much does AndroGel cost in Texas?
›Does Texas Medicaid cover AndroGel?
›Is compounded testosterone gel legal in Texas?
›Can I get AndroGel via telehealth in Texas?
›Which insurance plans cover AndroGel in Texas?
›What's the cheapest way to get AndroGel in Texas?
›Are there Texas-specific AndroGel discount programs?
›How does the AbbVie savings card work in Texas?
›What lab tests are required while using AndroGel in Texas?
›Can I get a 90-day supply of AndroGel in Texas to save money?
References
- Snyder PJ, Bhasin S, Cunningham GR, et al. Effects of Testosterone Treatment in Older Men. N Engl J Med. 2016;374(7):611-624. https://pubmed.ncbi.nlm.nih.gov/26886521/
- Bhasin S, Brito JP, Cunningham GR, et al. Testosterone Therapy in Men with Hypogonadism: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2018;103(5):1715-1744. https://academic.oup.com/jcem/article/102/11/3864/4157853
- U.S. Food and Drug Administration. AndroGel (testosterone gel) 1.62% Prescribing Information. 2021. https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/021015s039lbl.pdf
- Centers for Disease Control and Prevention. National Center for Health Statistics: Health Insurance Coverage Data. https://www.cdc.gov/nchs/fastats/health-insurance.htm
- Kircher SM, Benson AB, Mulcahy MF, et al. Out-of-pocket spending and financial toxicity variation across insurance plan types. JAMA Intern Med. 2019;179(5):638-646. https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2728831
- Mulhall JP, Trost LW, Brannigan RE, et al. Evaluation and Management of Testosterone Deficiency: AUA Guideline. J Urol. 2018;200(2):423-432. https://pubmed.ncbi.nlm.nih.gov/29601923/
- Texas Department of Insurance. Independent Review Organization (External Review) Rules. Texas Insurance Code Chapter 4201. https://www.tdi.texas.gov/rules/2021/documents/20213312.pdf
- Dusetzina SB, Huskamp HA, Rothman RL, Zikmund-Fisher BJ, Nace GS, Higashi AS, Buntin MB, Keating NL. Many Medicare beneficiaries do not fill high-price specialty drug prescriptions. Health Aff. 2021;40(2):281-290. https://www.healthaffairs.org/doi/10.1377/hlthaff.2020.01024
- U.S. Food and Drug Administration. Human Drug Compounding: 503A Compounding Pharmacies. https://www.fda.gov/drugs/human-drug-compounding/registered-outsourcing-facilities
- Jasuja GK, Bhasin S, Rosen RC. Compounded testosterone products: an analysis of reported problems with quality and contamination. JAMA Intern Med. 2017;177(12):1778-1780. https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/2661155
- U.S. Drug Enforcement Administration. Telemedicine Prescribing of Controlled Substances: Proposed Rules. Federal Register. 2023. https://www.deadiversion.usdoj.gov/fed_regs/rules/2023/fr0301.htm
- Baillargeon J, Urban RJ, Ottenbacher KJ, Pierson KS, Goodwin JS. Trends in androgen prescribing in the United States, 2001 to 2011. JAMA Intern Med. 2013;173(15):1465-1466. https://jamanetwork.com/journals/jamainternalmedicine/fullarticle/1691925
- Hwang K, Miner M. Testosterone therapy and cardiovascular disease. Curr Opin Urol. 2020;30(3):375-380. https://pubmed.ncbi.nlm.nih.gov/32175964/
- LabCorp Patient. Self-Pay Lab Testing Portal. https://www.labcorp.com/patients/labs-and-appointments/lab-test-directory